A legacy of excellence. A future of possibilities.

As a leader for nearly 20 years, Visualase™ laser ablation continues to drive the future of laser interstitial thermal therapy (LITT). The Visualase™ V2 platform builds on this leadership with updated automation, advanced laser safety capabilities, and greater system flexibility designed to support evolving workflow needs and operational efficiency.

Visualase V2 HCP hype edit

The Visualase™ V2 MRI-guided laser ablation system offers:

Precision by design

When every millimeter matters, you need confidence knowing that your visualization reflects what’s happening within the tissue.

Visualase™ laser ablation is the only cranial laser ablation system with true sub-millimetric voxel size.

Every voxel represents real data — not interpolated estimates — giving you more reliable information for confident decision-making.

  • Confidence in the ablation zone: More raw data points for unparalleled visualization and control, so that you can ablate only the tissue that matters, preserving healthy brain structures.
  • Reliable damage estimates: Validated histology-based thermal damage models for accurate calculation of necrosis and transitional tissue.
  • Expanded visualization options: Zoom, pan, and TDE opacity features for improved visualization of background images and thermal damage estimate.†

Control by design

Real-time safety checks for peace of mind and a streamlined procedure.

  • Fully automated MRI drift correction: Improved thermometry accuracy for entirety of the procedure.‡
  • Streamlined workflow: Intuitive, linear task flow improves overall software usability and consistency throughout the surgical workflow.
  • Smart automation: Bidirectional hardware and software controls reduce manual tasks and simplify troubleshooting.

Versatility by design

Investing in your patients today and tomorrow.

Visualase™ V2 workstation is an upgradeable, mobile laser ablation platform designed to keep care teams at the forefront of technology, with flexibility across multiple MRI scanners and FDA clearance for patients ages 2 and older.

FDA cleared with pediatric indication

The Visualase™ V2 system is FDA cleared to support a broader range of patients,† including children ages 2 years and older.

Partnership beyond products

For nearly 20 years, the Visualase™ portfolio has served patients with brain tumor and focal epilepsy in more procedures and across more countries than any other system.

Our mission is not just about the numbers – it’s about empowering healthcare professionals to make a true difference in the lives of patients and their families around the world.

Ready to unlock the future of LITT?

† Compared to Visualase™ V1 MRI-guided laser ablation system.

‡ As compared to no drift correction.

Rx only. Refer to product instruction manual/package insert for instructions, warnings, precautions, and contraindications.